Moreover, we also demonstrated superior tumor volume reduction and disease-specific survival in the SSTR2+ thyroid cancer xenograft mouse models with the use of 177Lu-DOTA-EB-TATE when compared to 177Lu-DOTA-TATE and177Lu-DOTA-JR11 (70). The gene discussed is SSTR2; the disease is thyroid gland carcinoma.